NASDAQ:TARS | Profit Breakdown | Tarsus Pharmaceuticals, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$173.91M-$19.91M-$18.55M
2026-03-31$162.05M-$6.12M-$6.97M
2025-12-31$151.67M-$7.98M-$8.37M
2025-09-30$118.7M-$14.53M-$12.59M
2025-06-30$102.66M-$22.18M-$20.34M
2025-03-31$78.34M-$26.28M-$25.12M
2024-12-31$66.41M-$24.42M-$23.11M
2024-09-30$48.12M-$25.16M-$23.42M
2024-06-30$40.81M-$33.3M-$33.29M
2024-03-31$27.61M-$37.68M-$35.73M
2023-12-31$13.08M-$44.45M-$41.9M
2023-09-30$1.87M-$40.94M-$39.15M
2023-06-30$0.00-$32.82M-$31.42M
2023-03-31$2.5M-$24.95M-$23.42M
2022-12-31$10M-$15.06M-$13.6M
2022-09-30$0.00-$22.91M-$22.51M
2022-06-30$15.28M-$5.22M-$5.74M
2022-03-31$539,000.00-$19.52M-$20.24M
2021-12-31$338,000.00-$14.45M-$14.85M
2021-09-30$1.24M-$15.71M-$15.7M
2021-06-30$22.02M$7.28M$6.35M
2021-03-31$33.43M$10.71M$10.38M
2020-12-31$0.00-$11.48M-$11.47M
2020-09-30$0.00-$10.14M-$10.14M
2020-06-30$0.00-$3.26M-$3.25M
2020-03-31$0.00-$2.12M-$1.96M
2019-12-31-$1.08M-$1.41M
2019-09-30-$633,000.00-$681,000.00
2019-06-30-$831,000.00
2019-03-31-$1.75M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$451.36M-$70.97M-$64.36M-$66.42M
2024-12-31$182.95M-$120.57M-$115.55M-$115.55M
2023-12-31$17.45M-$143.16M-$135.89M-$135.89M
2022-12-31$25.82M-$62.71M-$62.1M-$62.09M
2021-12-31$57.03M-$12.16M-$13.77M-$13.83M
2020-12-31$0.00-$27M-$26.81M-$26.81M
2019-12-31-$4.3M-$4.67M
2018-12-31-$1.32M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.